Inzirqo Powder, For Suspension
Product Images NDC 70954-522

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Inzirqo (NDC 70954-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inzirqo (Inzirqo)

This text provides information about a medication called hydrochlorothiazide (HCTZ). It gives details on the dosage strength in both dry powder and suspension form, reconstitution instructions, recommended storage conditions, and expiration date. It emphasizes keeping the medication away from children and includes the manufacturer's details.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.